Dr. Eva-Maria Borkenstein

Dr. Eva-Maria Borkenstein has built a solid and comprehensive foundation in ophthalmology over many years. Her professional pathled her from the Medical University of Graz through various hospitals to leading ophthalmic centers in the United States. Particularly formative were her years of training at the Wiener Privatklinik, Hanusch Hospital, and the Vienna General Hospital (AKHWien), where she first acquired a broad base in general medicine and plastic surgery under Prof. Dr. Hanno Millesi, before completing her specialist training in ophthalmology at the University Eye Hospital Graz.

An important milestone in her professional development was her Research Fellowship at the Wilmer Eye Institute of Johns Hopkins Universityin the United States—one of the world’s most renowned centers for ophthalmology. Under the supervision of Prof. Dr. A. Jun, she further deepened her expertise in corneal diseases and participated in large clinical studies. In addition, she completed the Bay Area Ophthalmology Courseat the Department of Ophthalmology, Stanford University School of Medicine—an advanced training program that significantly broadened her professional perspective.

After returning to Austria, she worked as a board-certified ophthalmologist at the ophthalmology department of the Styrian Health Insurance Fund (ambulatory care center) before co-founding Borkenstein & Borkensteinin Graz together with Dr. Andreas Borkenstein. There, she now covers the full spectrum of ophthalmology as a specialist. Through her additional training in plastic surgery, she has gained extensive experience in the treatment of eyelid malpositionsand periocular skin conditions—an area requiring precision and aesthetic sensitivity.

She further strengthened her scientific background during her time at the Department of Internal Medicine I at Vienna GeneralHospital (AKH), where she collaborated and published with Prof. Dr. P. Valent in basic research on anti-VEGF therapies — an area that today plays a key rolein the treatment of macular and retinal diseases. Early surgical training and work in plastic and aesthetic surgery with Prim. Dr. Dagmar Millesiin Vienna also contributed to the precise surgical approach that continues to characterize her work.

What particularly distinguishes Dr. Borkenstein is her meticulous approach to patient care. Many patients value her thoroughnessand the care she takes in carefully evaluating findings. She investigates clinical issues in depth and, when necessary, works in an interdisciplinary manner, as a holistic understanding of each case is especially important to her. She deliberately takes the time required for accurate diagnostics, comprehensive evaluation, and attentive care—an approach that has become increasingly rare in modern medicine.

She is a co-founder of Borkenstein & Borkenstein Research Laboratory GmbH, where she contributes to the design and execution of clinical studies and scientific projects. Together with Andreas Borkenstein, she regularly publishes in international peer-reviewed journals, translating research findings directly into daily clinical practice and ensuring that patient care remains consistently up to date.